FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2568113021> ?p ?o ?g. }

• W2568113021 abstract "Developmental disorders (DD), including autism spectrum disorder (ASD) and intellectual disability (ID), are a common group of clinical manifestations caused by a variety of genetic abnormalities. Genetic testing, including chromosomal microarray (CMA), plays an important role in diagnosing these conditions, but CMA can be limited by incomplete coverage of genetic abnormalities and lack of guidance for conditions rarely seen by treating physicians.We conducted a longitudinal, randomized controlled trial investigating the impact of a higher resolution 2.8 million (MM) probe-CMA test on the quality of care delivered by practicing general pediatricians and specialists. To overcome the twin problems of finding an adequate sample size of multiple rare conditions and under/incorrect diagnoses, we used standardized simulated patients known as CPVs. Physicians, randomized into control and intervention groups, cared for the CPV pediatric patients with DD/ASD/ID. Care responses were scored against evidence-based criteria. In round one, participants could order diagnostic tests including existing CMA tests. In round two, intervention physicians could order the 2.8MM probe-CMA test. Outcome measures included overall quality of care and quality of the diagnosis and treatment plan.Physicians ordering CMA testing had 5.43% (p<0.001) higher overall quality scores than those who did not. Intervention physicians ordering the 2.8MM probe-CMA test had 7.20% (p<0.001) higher overall quality scores. Use of the 2.8MM probe-CMA test led to a 10.9% (p<0.001) improvement in the diagnosis and treatment score. Introduction of the 2.8MM probe-CMA test led to significant improvements in condition-specific interventions including an 8.3% (p = 0.04) improvement in evaluation and therapy for gross motor delays caused by Hunter syndrome, a 27.5% (p = 0.03) increase in early cognitive intervention for FOXG1-related disorder, and an 18.2% (p<0.001) improvement in referrals to child neurology for Dravet syndrome.Physician use of the 2.8MM probe-CMA test significantly improves overall quality as well as diagnosis and treatment quality for simulated cases of pediatric DD/ASD/ID patients, and delivers additional clinical utility over existing CMA tests." @default.
• W2568113021 created "2017-01-13" @default.
• W2568113021 creator A5002509106 @default.
• W2568113021 creator A5011050752 @default.
• W2568113021 creator A5014134809 @default.
• W2568113021 creator A5021150258 @default.
• W2568113021 creator A5028316558 @default.
• W2568113021 creator A5052032020 @default.
• W2568113021 creator A5052648945 @default.
• W2568113021 creator A5053616850 @default.
• W2568113021 creator A5066516005 @default.
• W2568113021 date "2016-12-30" @default.
• W2568113021 modified "2023-09-27" @default.
• W2568113021 title "Clinical Utility of a Comprehensive, Whole Genome CMA Testing Platform in Pediatrics: A Prospective Randomized Controlled Trial of Simulated Patients in Physician Practices" @default.
• W2568113021 cites W1804020951 @default.
• W2568113021 cites W1835752389 @default.
• W2568113021 cites W1900359819 @default.
• W2568113021 cites W1964762045 @default.
• W2568113021 cites W1971517184 @default.
• W2568113021 cites W1980096475 @default.
• W2568113021 cites W1995971511 @default.
• W2568113021 cites W2006843613 @default.
• W2568113021 cites W2021856717 @default.
• W2568113021 cites W2025210241 @default.
• W2568113021 cites W2041585205 @default.
• W2568113021 cites W2061706174 @default.
• W2568113021 cites W2063901568 @default.
• W2568113021 cites W2078300952 @default.
• W2568113021 cites W2113656077 @default.
• W2568113021 cites W2116322933 @default.
• W2568113021 cites W2119379172 @default.
• W2568113021 cites W2131587128 @default.
• W2568113021 cites W2153438724 @default.
• W2568113021 cites W2163623694 @default.
• W2568113021 cites W2165974787 @default.
• W2568113021 cites W2166014535 @default.
• W2568113021 cites W2167373003 @default.
• W2568113021 cites W2167571715 @default.
• W2568113021 cites W2183255567 @default.
• W2568113021 cites W2224420914 @default.
• W2568113021 cites W4211201735 @default.
• W2568113021 cites W4239939639 @default.
• W2568113021 cites W4247234717 @default.
• W2568113021 doi "https://doi.org/10.1371/journal.pone.0169064" @default.
• W2568113021 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5201278" @default.
• W2568113021 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28036350" @default.
• W2568113021 hasPublicationYear "2016" @default.
• W2568113021 type Work @default.
• W2568113021 sameAs 2568113021 @default.
• W2568113021 citedByCount "5" @default.
• W2568113021 countsByYear W25681130212017 @default.
• W2568113021 countsByYear W25681130212019 @default.
• W2568113021 countsByYear W25681130212020 @default.
• W2568113021 crossrefType "journal-article" @default.
• W2568113021 hasAuthorship W2568113021A5002509106 @default.
• W2568113021 hasAuthorship W2568113021A5011050752 @default.
• W2568113021 hasAuthorship W2568113021A5014134809 @default.
• W2568113021 hasAuthorship W2568113021A5021150258 @default.
• W2568113021 hasAuthorship W2568113021A5028316558 @default.
• W2568113021 hasAuthorship W2568113021A5052032020 @default.
• W2568113021 hasAuthorship W2568113021A5052648945 @default.
• W2568113021 hasAuthorship W2568113021A5053616850 @default.
• W2568113021 hasAuthorship W2568113021A5066516005 @default.
• W2568113021 hasBestOaLocation W25681130211 @default.
• W2568113021 hasConcept C118552586 @default.
• W2568113021 hasConcept C126322002 @default.
• W2568113021 hasConcept C142724271 @default.
• W2568113021 hasConcept C151730666 @default.
• W2568113021 hasConcept C168563851 @default.
• W2568113021 hasConcept C17744445 @default.
• W2568113021 hasConcept C187212893 @default.
• W2568113021 hasConcept C199539241 @default.
• W2568113021 hasConcept C2777267654 @default.
• W2568113021 hasConcept C2779473830 @default.
• W2568113021 hasConcept C2780665704 @default.
• W2568113021 hasConcept C2780673598 @default.
• W2568113021 hasConcept C534262118 @default.
• W2568113021 hasConcept C535046627 @default.
• W2568113021 hasConcept C71924100 @default.
• W2568113021 hasConcept C86803240 @default.
• W2568113021 hasConceptScore W2568113021C118552586 @default.
• W2568113021 hasConceptScore W2568113021C126322002 @default.
• W2568113021 hasConceptScore W2568113021C142724271 @default.
• W2568113021 hasConceptScore W2568113021C151730666 @default.
• W2568113021 hasConceptScore W2568113021C168563851 @default.
• W2568113021 hasConceptScore W2568113021C17744445 @default.
• W2568113021 hasConceptScore W2568113021C187212893 @default.
• W2568113021 hasConceptScore W2568113021C199539241 @default.
• W2568113021 hasConceptScore W2568113021C2777267654 @default.
• W2568113021 hasConceptScore W2568113021C2779473830 @default.
• W2568113021 hasConceptScore W2568113021C2780665704 @default.
• W2568113021 hasConceptScore W2568113021C2780673598 @default.
• W2568113021 hasConceptScore W2568113021C534262118 @default.
• W2568113021 hasConceptScore W2568113021C535046627 @default.
• W2568113021 hasConceptScore W2568113021C71924100 @default.
• W2568113021 hasConceptScore W2568113021C86803240 @default.
• W2568113021 hasLocation W25681130211 @default.
• W2568113021 hasLocation W25681130212 @default.
• W2568113021 hasLocation W25681130213 @default.
• W2568113021 hasLocation W25681130214 @default.

• next